Advertisement

Pediatric Acute Respiratory Distress Syndrome in Immunocompromised Patients

  • Courtney M. RowanEmail author
Chapter

Abstract

Immunocompromised children are at high risk for both the development of pediatric acute respiratory distress syndrome (PARDS) and PARDS-related mortality. This complex population seems to be growing, and overall critical care outcomes are improving. When the immunocompromised child develops acute hypoxic respiratory failure, careful deliberation for a diagnostic workup must be done, since this population is at risk for both infectious and noninfectious pulmonary complications. Given the risk for severe PARDS, if noninvasive respiratory support strategies are attempted, they should be done so early in the disease course. If invasive mechanical ventilation is applied, a focus should be placed on lung-protective strategies. Throughout the critical illness, it is important to have ongoing multispecialty collaboration and consideration of the status of the underlying immunocompromising condition. We will explore many of these issues in this chapter.

Keywords

ARDS Immunocompromised host Neoplasms Hematopoietic stem cell transplantation Pediatrics 

References

  1. 1.
    Azoulay E, Pene F, Darmon M, Lengline E, Benoit D, Soares M, et al. Managing critically ill hematology patients: time to think differently. Blood Rev. 2015;29(6):359–67.PubMedCrossRefGoogle Scholar
  2. 2.
    Tamburro RF, Barfield RC, Shaffer ML, Rajasekaran S, Woodard P, Morrison RR, et al. Changes in outcomes (1996–2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med. 2008;9(3):270–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Rowan CM, Gertz SJ, McArthur J, Fitzgerald JC, Nitu ME, Loomis A, et al. Invasive mechanical ventilation and mortality in pediatric hematopoietic stem cell transplantation: a multicenter study. Pediatr Crit Care Med. 2016;17(4):294–302.PubMedCrossRefGoogle Scholar
  4. 4.
    Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, et al. Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. Pediatr Crit Care Med. 2013;14(3):261–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Flori H, Dahmer MK, Sapru A, Quasney MW, Pediatric Acute Lung Injury Consensus Conference G. Comorbidities and assessment of severity of pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015;16(5 Suppl 1):S41–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Erickson S, Schibler A, Numa A, Nuthall G, Yung M, Pascoe E, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med. 2007;8(4):317–23.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293(4):470–6.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Pediatric Acute Lung Injury Consensus Conference G. Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015;16(5):428–39.CrossRefGoogle Scholar
  9. 9.
    Rowan CM, Smith LS, Loomis A, McArthur J, Gertz SJ, Fitzgerald JC, et al. Pediatric acute respiratory distress syndrome in pediatric allogeneic hematopoietic stem cell transplants – a multicenter study. Pediatr Crit Care Med. 2017;Google Scholar
  10. 10.
    Upperman JS, Lacroix J, Curley MA, Checchia PA, Lee DW, Cooke KR, et al. Specific etiologies associated with the multiple organ dysfunction syndrome in children: part 1. Pediatr Crit Care Med. 2017;18(3_suppl Suppl 1):S50–S7.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Lindell RB, Gertz SJ, Rowan CM, McArthur J, Beske F, Plunkett A, et al. High levels of morbidity and mortality among pediatric hematopoietic cell transplant recipients with severe Sepsis: insights from the Sepsis PRevalence, OUtcomes, and therapies international point prevalence study. Pediatr Crit Care Med. 2017;Google Scholar
  12. 12.
    Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601–14.PubMedCrossRefGoogle Scholar
  13. 13.
    British Thoracic Society Bronchoscopy Guidelines Committee aSoSoCCoBTS. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax. 2001;56(Suppl 1):i1–21.Google Scholar
  14. 14.
    Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest. 2004;125(2):712–22.PubMedCrossRefGoogle Scholar
  15. 15.
    Allen KA, Markin RS, Rennard SI, Shaw BW Jr, Thompson AB, Wood RP, et al. Bronchoalveolar lavage in liver transplant patients. Acta Cytol. 1989;33(4):539–43.PubMedGoogle Scholar
  16. 16.
    Azoulay E, Mokart D, Rabbat A, Pene F, Kouatchet A, Bruneel F, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med. 2008;36(1):100–7.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Kasow KA, King E, Rochester R, Tong X, Srivastava DK, Horwitz EM, et al. Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990–2002. Biol Blood Marrow Transplant. 2007;13(7):831–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Zinter MS, Dvorak CC, Mayday MY, Iwanaga K, Ly NP, McGarry ME, et al. Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children. Clin Infect Dis. 2018; 68(11):1847–5.Google Scholar
  19. 19.
    Visner GA, Faro A, Zander DS. Role of transbronchial biopsies in pediatric lung diseases. Chest. 2004;126(1):273–80.PubMedCrossRefGoogle Scholar
  20. 20.
    Chan CC, Abi-Saleh WJ, Arroliga AC, Stillwell PC, Kirby TJ, Gordon SM, et al. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant. 1996;15(2):196–205.PubMedGoogle Scholar
  21. 21.
    Rano A, Agusti C, Jimenez P, Angrill J, Benito N, Danes C, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax. 2001;56(5):379–87.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Patel NR, Lee PS, Kim JH, Weinhouse GL, Koziel H. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients. Chest. 2005;127(4):1388–96.PubMedGoogle Scholar
  23. 23.
    Efrati O, Gonik U, Bielorai B, Modan-Moses D, Neumann Y, Szeinberg A, et al. Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer. Pediatr Blood Cancer. 2007;48(3):324–9.PubMedCrossRefGoogle Scholar
  24. 24.
    McWilliams TJ, Williams TJ, Whitford HM, Snell GI. Surveillance bronchoscopy in lung transplant recipients: risk versus benefit. J Heart Lung Transplant. 2008;27(11):1203–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med. 2010;182(8):1038–46.PubMedCrossRefGoogle Scholar
  26. 26.
    Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45(4):647–55.PubMedCrossRefGoogle Scholar
  27. 27.
    Hohenadel IA, Kiworr M, Genitsariotis R, Zeidler D, Lorenz J. Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen. Thorax. 2001;56(2):115–20.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Furuya ME, Ramirez-Figueroa JL, Vargas MH, Bernaldez-Rios R, Vazquez-Rosales JG, Rodriguez-Velasco A. Diagnoses unveiled by early bronchoscopy in children with leukemia and pulmonary infiltrates. J Pediatr Hematol Oncol. 2012;34(8):596–600.PubMedCrossRefGoogle Scholar
  29. 29.
    Pereira Gomes JC, Pedreira WL Jr, Araujo EM, Soriano FG, Negri EM, Antonangelo L, et al. Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy. Chest. 2000;118(6):1739–46.PubMedCrossRefGoogle Scholar
  30. 30.
    Kuehnhardt D, Hannemann M, Schmidt B, Heider U, Possinger K, Eucker J. Therapeutic implication of BAL in patients with neutropenia. Ann Hematol. 2009;88(12):1249–56.PubMedCrossRefGoogle Scholar
  31. 31.
    Cereser L, Zuiani C, Graziani G, Girometti R, Como G, Zaja F, et al. Impact of clinical data on chest radiography sensitivity in detecting pulmonary abnormalities in immunocompromised patients with suspected pneumonia. Radiol Med. 2010;115(2):205–14.PubMedCrossRefGoogle Scholar
  32. 32.
    Heitkamp DE, Albin MM, Chung JH, Crabtree TP, Iannettoni MD, Johnson GB, et al. ACR Appropriateness Criteria(R) acute respiratory illness in immunocompromised patients. J Thorac Imaging. 2015;30(3):W2–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Lemiale V, Mokart D, Mayaux J, Lambert J, Rabbat A, Demoule A, et al. The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial. Crit Care. 2015;19:380.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Lemiale V, Resche-Rigon M, Mokart D, Pene F, Argaud L, Mayaux J, et al. High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study. Crit Care Med. 2017;45(3):e274–e80.PubMedCrossRefGoogle Scholar
  35. 35.
    Harada K, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Ikegawa S, et al. Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease. Springerplus. 2016;5:512.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Antonelli M, Conti G, Moro ML, Esquinas A, Gonzalez-Diaz G, Confalonieri M, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med. 2001;27(11):1718–28.PubMedCrossRefGoogle Scholar
  37. 37.
    Antonelli M, Conti G, Bufi M, Costa MG, Lappa A, Rocco M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA. 2000;283(2):235–41.PubMedCrossRefGoogle Scholar
  38. 38.
    Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001;344(7):481–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Lemiale V, Mokart D, Resche-Rigon M, Pene F, Mayaux J, Faucher E, et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA. 2015;314(16):1711–9.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Squadrone V, Massaia M, Bruno B, Marmont F, Falda M, Bagna C, et al. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med. 2010;36(10):1666–74.PubMedCrossRefGoogle Scholar
  41. 41.
    Essouri S, Carroll C, Pediatric Acute Lung Injury Consensus Conference G. Noninvasive support and ventilation for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015;16(5 Suppl 1):S102–10.PubMedCrossRefGoogle Scholar
  42. 42.
    Pancera CF, Hayashi M, Fregnani JH, Negri EM, Deheinzelin D, de Camargo B. Noninvasive ventilation in immunocompromised pediatric patients: eight years of experience in a pediatric oncology intensive care unit. J Pediatr Hematol Oncol. 2008;30(7):533–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Piastra M, De Luca D, Pietrini D, Pulitano S, D’Arrigo S, Mancino A, et al. Noninvasive pressure-support ventilation in immunocompromised children with ARDS: a feasibility study. Intensive Care Med. 2009;35(8):1420–7.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Murase K, Chihara Y, Takahashi K, Okamoto S, Segawa H, Fukuda K, et al. Use of noninvasive ventilation for pediatric patients after liver transplantation: decrease in the need for reintubation. Liver Transpl. 2012;18(10):1217–25.PubMedCrossRefGoogle Scholar
  45. 45.
    Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40(8):1106–14.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Lemiale V, Lambert J, Canet E, Mokart D, Pene F, Rabbat A, et al. Identifying cancer subjects with acute respiratory failure at high risk for intubation and mechanical ventilation. Respir Care. 2014;59(10):1517–23.PubMedCrossRefGoogle Scholar
  47. 47.
    Rowan CM, McArthur J, Hsing DD, Gertz SJ, Smith LS, Loomis A, et al. Acute respiratory failure in pediatric hematopoietic cell transplantation: a multicenter study. Crit Care Med. 2018;46(10):e967–e74.PubMedCrossRefGoogle Scholar
  48. 48.
    Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301–8.Google Scholar
  49. 49.
    Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338(6):347–54.PubMedCrossRefGoogle Scholar
  50. 50.
    Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747–55.PubMedCrossRefGoogle Scholar
  51. 51.
    Rimensberger PC, Cheifetz IM, Pediatric Acute Lung Injury Consensus Conference G. Ventilatory support in children with pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015;16(5 Suppl 1):S51–60.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Khemani RG, Conti D, Alonzo TA, Bart RD 3rd, Newth CJ. Effect of tidal volume in children with acute hypoxemic respiratory failure. Intensive Care Med. 2009;35(8):1428–37.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Phoenix SI, Paravastu S, Columb M, Vincent JL, Nirmalan M. Does a higher positive end expiratory pressure decrease mortality in acute respiratory distress syndrome? A systematic review and meta-analysis. Anesthesiology. 2009;110(5):1098–105.PubMedCrossRefGoogle Scholar
  54. 54.
    Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010;303(9):865–73.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Soubani AO, Pandya CM. The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2010;3(3):143–57.PubMedCrossRefGoogle Scholar
  56. 56.
    Staitieh B, Guidot DM. Noninfectious pulmonary complications of human immunodeficiency virus infection. Am J Med Sci. 2014;348(6):502–11.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327–36.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Khemani RG, Parvathaneni K, Yehya N, Bhalla AK, Thomas NJ, Newth CJL. Positive end-expiratory pressure lower than the ARDS network protocol is associated with higher pediatric acute respiratory distress syndrome mortality. Am J Respir Crit Care Med. 2018;198(1):77–89.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Trachsel D, McCrindle BW, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2005;172(2):206–11.PubMedCrossRefGoogle Scholar
  60. 60.
    Rowan CM, Hege KM, Speicher RH, Goodman M, Perkins SM, Slaven JE, et al. Oxygenation index predicts mortality in pediatric stem cell transplant recipients requiring mechanical ventilation. Pediatr Transplant. 2012;16(6):645–50.PubMedCrossRefGoogle Scholar
  61. 61.
    van Gestel JP, Bierings MB, Dauger S, Dalle JH, Pavlicek P, Sedlacek P, et al. Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry. Bone Marrow Transplant. 2014;49(10):1287–92.PubMedCrossRefGoogle Scholar
  62. 62.
    Rettig JS, Smallwood CD, Walsh BK, Rimensberger PC, Bachman TE, Bollen CW, et al. High-frequency oscillatory ventilation in pediatric acute lung injury: a multicenter international experience. Crit Care Med. 2015;43(12):2660–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Faqih NA, Qabba’h SH, Rihani RS, Ghonimat IM, Yamani YM, Sultan IY. The use of high frequency oscillatory ventilation in a pediatric oncology intensive care unit. Pediatr Blood Cancer. 2012;58(3):384–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Yehya N, Topjian AA, Thomas NJ, Friess SH. Improved oxygenation 24 hours after transition to airway pressure release ventilation or high-frequency oscillatory ventilation accurately discriminates survival in immunocompromised pediatric patients with acute respiratory distress syndrome∗. Pediatr Crit Care Med. 2014;15(4):e147–56.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Rowan CM, Loomis A, McArthur J, Smith LS, Gertz SJ, Fitzgerald JC, et al. High-frequency oscillatory ventilation use and severe pediatric ARDS in the pediatric hematopoietic cell transplant recipient. Respir Care. 2018;63(4):404–11.PubMedCrossRefGoogle Scholar
  66. 66.
    Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus PT, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med. 2014;189(11):1374–82.PubMedCrossRefGoogle Scholar
  67. 67.
    Schmidt M, Zogheib E, Roze H, Repesse X, Lebreton G, Luyt CE, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013;39(10):1704–13.PubMedCrossRefGoogle Scholar
  68. 68.
    Enger T, Philipp A, Videm V, Lubnow M, Wahba A, Fischer M, et al. Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study. Crit Care. 2014;18(2):R67.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Bailly DK, Reeder RW, Zabrocki LA, Hubbard AM, Wilkes J, Bratton SL, et al. Development and validation of a score to predict mortality in children undergoing extracorporeal membrane oxygenation for respiratory failure: pediatric pulmonary rescue with extracorporeal membrane oxygenation prediction score. Crit Care Med. 2017;45(1):e58–66.PubMedCrossRefGoogle Scholar
  70. 70.
    Gow KW, Heiss KF, Wulkan ML, Katzenstein HM, Rosenberg ES, Heard ML, et al. Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: the extracorporeal life support experience. Crit Care Med. 2009;37(4):1308–16.PubMedCrossRefGoogle Scholar
  71. 71.
    Wohlfarth P, Ullrich R, Staudinger T, Bojic A, Robak O, Hermann A, et al. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care. 2014;18(1):R20.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Smith S, Butt W, Best D, MacLaren G. Long-term survival after extracorporeal life support in children with neutropenic sepsis. Intensive Care Med. 2016;42(5):942–3.PubMedCrossRefGoogle Scholar
  73. 73.
    Wohlfarth P, Beutel G, Lebiedz P, Stemmler HJ, Staudinger T, Schmidt M, et al. Characteristics and outcome of patients after allogeneic hematopoietic stem cell transplantation treated with extracorporeal membrane oxygenation for acute respiratory distress syndrome. Crit Care Med. 2017;45(5):e500–e7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Pediatrics, Division of Critical CareIndiana University School of MedicineIndianapolisUSA

Personalised recommendations